CN Patent
CN121487757A — 含有脂质-聚氨基酸缀合物的超声响应性囊泡
Assigned to Bracco Suisse SA · Expires 2026-02-06 · 0y expired
What this patent protects
本发明总体上涉及超声造影剂(USCA)领域。特别地,本发明涉及包含内核和外层的超声响应性囊泡,其中所述内核包含选自气体、呈液体形式的气体前体或其混合物的生理学上可接受的化合物,并且所述外层包含式(I)的脂质‑聚氨基酸缀合物。本发明还涉及包含多个所述超声响应性囊泡的悬浮液,以及涉及用于体内成像方法的所述悬浮液。 (I)
USPTO Abstract
本发明总体上涉及超声造影剂(USCA)领域。特别地,本发明涉及包含内核和外层的超声响应性囊泡,其中所述内核包含选自气体、呈液体形式的气体前体或其混合物的生理学上可接受的化合物,并且所述外层包含式(I)的脂质‑聚氨基酸缀合物。本发明还涉及包含多个所述超声响应性囊泡的悬浮液,以及涉及用于体内成像方法的所述悬浮液。 (I)
Drugs covered by this patent
- sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.